North American COVID-19 Myocardial Infarction (NACMI) Risk Score for Prediction of In-Hospital Mortality

[1]  C. Grines,et al.  Sex Differences in Clinical Characteristics, Management Strategies, and Outcomes of STEMI With COVID-19: NACMI Registry , 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

[2]  Keshav R. Nayak,et al.  Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19 , 2022, Journal of the American College of Cardiology.

[3]  K. Wood,et al.  Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction. , 2021, JAMA.

[4]  T. Murohara,et al.  In-hospital mortality among consecutive patients with ST-Elevation myocardial infarction in modern primary percutaneous intervention era ~ Insights from 15-year data of single-center hospital-based registry ~ , 2021, PloS one.

[5]  B. Gersh,et al.  International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19 , 2021, Journal of the American College of Cardiology.

[6]  R. Kornowski,et al.  The Clinical Challenge of ST-Segment Elevation Myocardial Infarction and COVID-19. , 2021, Journal of the American College of Cardiology.

[7]  Brian C. Case,et al.  Initial Findings From the North American COVID-19 Myocardial Infarction Registry , 2021, Journal of the American College of Cardiology.

[8]  P. Adibi,et al.  Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study , 2021, BMC Medical Research Methodology.

[9]  G. Condorelli,et al.  A risk score based on baseline risk factors for predicting mortality in COVID-19 patients , 2021, Current medical research and opinion.

[10]  A. Salonia,et al.  Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis , 2021, Reviews in Endocrine and Metabolic Disorders.

[11]  B. Ibrahim,et al.  Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis , 2020, Intervirology.

[12]  I. Cavero-Redondo,et al.  Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions , 2020, PloS one.

[13]  K. Khunti,et al.  Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study , 2020, The Lancet Diabetes & Endocrinology.

[14]  C. Schmidt,et al.  Clinical Characteristics and Outcomes of STEMI Patients With Cardiogenic Shock and Cardiac Arrest. , 2020, JACC. Cardiovascular interventions.

[15]  Keshav R. Nayak,et al.  North American COVID-19 ST-Segment-Elevation Myocardial Infarction (NACMI) registry: Rationale, design, and implications , 2020, American Heart Journal.

[16]  Ezekiel J Emanuel,et al.  Fair Allocation of Scarce Medical Resources in the Time of Covid-19. , 2020, The New England journal of medicine.

[17]  Lei Dong,et al.  Kidney disease is associated with in-hospital death of patients with COVID-19 , 2020, Kidney International.

[18]  R. Antonelli-Incalzi,et al.  Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary hypertension , 2019, Diabetes/metabolism research and reviews.

[19]  D. Morrow,et al.  Classification of Deaths in Cardiovascular Outcomes Trials: Known Unknowns and Unknown Unknowns , 2019, Circulation.

[20]  L. Rosella,et al.  Acute Myocardial Infarction after Laboratory‐Confirmed Influenza Infection , 2018, The New England journal of medicine.

[21]  J. Spertus,et al.  Predicting In-Hospital Mortality in Patients With Acute Myocardial Infarction. , 2016, Journal of the American College of Cardiology.

[22]  L. Dušek,et al.  GRACE Score among Six Risk Scoring Systems (CADILLAC, PAMI, TIMI, Dynamic TIMI, Zwolle) Demonstrated the Best Predictive Value for Prediction of Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction , 2015, PloS one.

[23]  Gary S Collins,et al.  Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration , 2015, Annals of Internal Medicine.

[24]  C. Di Mario,et al.  Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. , 2014, European heart journal.

[25]  E. Antman,et al.  Dynamic TIMI Risk Score for STEMI , 2013, Journal of the American Heart Association.

[26]  N. Obuchowski,et al.  Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.

[27]  V. Zarubaev,et al.  Clinical Research , 2022 .

[28]  Á. Avezum,et al.  Predictors of hospital mortality in the global registry of acute coronary events. , 2003, Archives of internal medicine.

[29]  J. Peiris,et al.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study , 2003, The Lancet.

[30]  M. Cooper,et al.  Prevention of Accelerated Atherosclerosis by Angiotensin-Converting Enzyme Inhibition in Diabetic Apolipoprotein E–Deficient Mice , 2002, Circulation.

[31]  E. Antman,et al.  TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy , 2000, Circulation.